Keyphrases
South Africa
100%
Johannesburg
54%
Antiretroviral Therapy
51%
Treatment Outcome
29%
HIV Treatment
26%
Public Sector
26%
Virological Failure
23%
Confidence Interval
20%
First-line Antiretroviral Therapy
20%
Tenofovir
20%
CD4 Count
19%
HIV Patients
17%
South African
16%
Attrition
16%
Loss-to-follow-up
16%
Antiretroviral Therapy Initiation
14%
Nevirapine
14%
Tuberculosis
14%
Efavirenz
14%
Cohort Analysis
13%
United States
12%
Nave
12%
Resource-limited Settings
11%
HIV-positive
11%
Stavudine
10%
Xpert
10%
HIV Clinics
9%
HIV Care
9%
Second-line Antiretroviral Therapy
9%
Lost to Follow-up
8%
Patient-initiated
8%
AIDS/HIV
8%
Treatment Initiation
7%
Lamivudine
7%
TB Treatment
7%
Risk Ratio
7%
Viral Load
7%
HIV Testing
7%
Universal Testing
6%
National TB Program
6%
Breast Care
6%
Depressive Symptoms
6%
Randomized Controlled Trial
6%
Rifampicin-resistant Tuberculosis
6%
National ID
6%
Home Visits
6%
HIV Care Continuum
6%
Facility-based
6%
Treatment Facilities
6%
Breastfeeding Benefits
6%
Medicine and Dentistry
Human Immunodeficiency Virus
96%
Antiretroviral Therapy
62%
Tenofovir
19%
Nevirapine
13%
Cohort Analysis
13%
Efavirenz
13%
Prophylaxis
12%
Stavudine
10%
Proportional Hazards Model
9%
Health Care Provider
8%
Health Care Cost
7%
HIV Test
7%
Cohort Study
7%
Primary Health Care
7%
Sputum
7%
Health Outcomes
7%
Multidrug Resistant Tuberculosis
7%
Lamivudine
7%
High Risk Population
6%
Low and Middle Income Countries
6%
Short Course Therapy
6%
HIV Therapy
6%
Rifampicin
6%
Non Communicable Disease
6%
Disseminated Herpes Zoster
6%
Gene Linkage
6%
Maternal Welfare
6%
Reverse-Transcriptase Inhibitor
6%
Proteinase Inhibitor
6%
Lung Tuberculosis
6%
Nonnucleoside Reverse Transcriptase Inhibitor
6%
Hospital Mortality
6%
Condom Use
6%
Malignant Neoplasm
6%
Randomized Controlled Trial
6%
Systematic Review
6%
Drug Resistant Tuberculosis
6%
Symptom
5%
